Elsbernd Brian
Insider CIK 1763511 · CPRX Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,776 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 10,322 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 7,067 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 98,652 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 126,704 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 147,621 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 69,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 135,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 200,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 132,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 242,501 | $31.50 | $7.64M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 956,142 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 245,124 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-29 | 2025-12-30 | 2,623 | — | $0 | 242,501 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 7,067 | — | $0 | 962,809 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 7,067 | — | $0 | 241,237 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-08 | 2025-12-10 | 2,780 | — | $0 | 238,457 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 5,161 | — | $0 | 969,876 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-11-21 | 2025-11-24 | 2,030 | — | $0 | 234,170 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 5,161 | — | $0 | 236,200 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 29,776 | — | $0 | 975,037 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 98,652 | — | $0 | 945,161 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-11-12 | 2025-11-14 | 40,000 | $22.70 | $908.0K | 231,039 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-09-08 | 2025-09-10 | 112,475 | — | $0 | 846,609 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-09-08 | 2025-09-10 | 30,000 | $20.30 | $609.0K | 271,039 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-09-08 | 2025-09-10 | 112,475 | $2.24 | $251.9K | 301,039 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-09-04 | 2025-09-05 | 30,000 | — | $0 | 959,084 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-09-04 | 2025-09-05 | 30,000 | $2.24 | $67.2K | 218,564 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-09-04 | 2025-09-05 | 30,000 | $19.52 | $585.6K | 188,564 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-09-03 | 2025-09-05 | 20,000 | — | $0 | 989,084 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-09-03 | 2025-09-05 | 20,000 | $20.08 | $401.6K | 188,564 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-09-03 | 2025-09-05 | 20,000 | $2.24 | $44.8K | 208,564 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-03-03 | 2025-03-05 | 9,270 | — | $0 | 1,062,339 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-03-03 | 2025-03-05 | 53,255 | — | $0 | 1,009,084 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 53,255 | $22.93 | $1.22M | 188,564 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-03-03 | 2025-03-05 | 53,255 | $2.24 | $119.3K | 241,819 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 9,720 | $23.23 | $225.8K | 188,564 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-03-03 | 2025-03-05 | 9,270 | $2.24 | $20.8K | 197,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 9,667 | — | $0 | 1,071,609 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 9,667 | — | $0 | 190,917 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-02-14 | 2025-02-19 | 2,353 | — | $0 | 188,564 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 6,667 | — | $0 | 1,081,276 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 6,667 | — | $0 | 183,191 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-27 | 2024-12-31 | 1,941 | — | $0 | 181,250 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 7,067 | — | $0 | 1,087,943 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-09 | 2024-12-11 | 1,720 | — | $0 | 176,524 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 7,067 | — | $0 | 178,244 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-26 | 2024-11-29 | 50,244 | — | $0 | 1,104,766 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-26 | 2024-11-29 | 9,756 | — | $0 | 1,095,010 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-26 | 2024-11-29 | 3,956 | $21.58 | $85.4K | 171,177 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-26 | 2024-11-29 | 50,244 | $4.01 | $201.5K | 174,677 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-26 | 2024-11-29 | 9,300 | $21.65 | $201.3K | 165,377 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-26 | 2024-11-29 | 9,756 | $4.01 | $39.1K | 175,133 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 15,483 | — | $0 | 1,155,010 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 126,704 | — | $0 | 1,139,527 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-03-27 | 2024-03-28 | 25,000 | $16.44 | $411.0K | 124,433 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 9,667 | — | $0 | 1,012,823 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 9,667 | — | $0 | 151,786 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-02-15 | 2024-02-16 | 2,353 | — | $0 | 149,433 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 6,666 | — | $0 | 1,022,490 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 6,666 | — | $0 | 144,742 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-12-27 | 2023-12-29 | 2,623 | — | $0 | 142,119 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 147,621 | — | $0 | 1,007,955 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 21,201 | — | $0 | 1,029,156 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-03-20 | 2023-03-22 | 50,000 | — | $0 | 860,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-20 | 2023-03-22 | 50,000 | $16.07 | $803.5K | 138,076 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-03-20 | 2023-03-22 | 50,000 | $1.13 | $56.5K | 188,076 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 9,666 | — | $0 | 910,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 9,666 | — | $0 | 140,429 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-02-15 | 2023-02-17 | 2,353 | — | $0 | 138,076 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 20,000 | — | $0 | 920,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 69,000 | — | $0 | 900,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 14,667 | — | $0 | 831,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 14,667 | — | $0 | 130,763 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-11-14 | 2022-11-15 | 40,000 | — | $0 | 845,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-11-14 | 2022-11-15 | 65,000 | — | $0 | 885,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-11-14 | 2022-11-15 | 40,000 | $0.79 | $31.6K | 116,096 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-11-14 | 2022-11-15 | 65,000 | $1.85 | $120.3K | 76,096 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-11 | 2022-11-15 | 14,666 | $16.24 | $238.2K | 11,096 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 29,000 | — | $0 | 950,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 135,000 | — | $0 | 921,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 14,667 | — | $0 | 786,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 14,667 | — | $0 | 29,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2021-12-03 | 2021-12-06 | 3,571 | — | $0 | 25,762 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 200,000 | — | $0 | 801,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-22 | 2020-12-23 | 14,666 | — | $0 | 601,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-23 | 14,666 | — | $0 | 14,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 44,000 | — | $0 | 616,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 132,000 | — | $0 | 572,000 | SEC↗ |